Complete Revascularization of Stable STEMI Patients Offers a Significant Benefit if Done During the Index PCI, but Not if It’s Done as a Staged Procedure

References

• O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485–510.
   PubMed Web of Science ®Google Scholar
• Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019–2027. doi:10.1001/jama.2014.15095
   PubMed Web of Science ®Google Scholar
• Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386(9994):665–671. doi:10.1016/S0140-6736(15)60648-1
   PubMed Web of Science ®Google Scholar
• Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65(10):963–972. doi:10.1016/j.jacc.2014.12.038
   PubMed Web of Science ®Google Scholar
• Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369(12):1115–1123. doi:10.1056/NEJMoa1305520
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: an Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol. 2016;67(10):1235–1250. doi:10.1016/j.jacc.2015.10.005
   PubMed Web of Science ®Google Scholar
• Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381(15):1411–1421. doi:10.1056/NEJMoa1907775
   PubMed Web of Science ®Google Scholar
• Pavasini R, Biscaglia S, Barbato E, et al. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2019. doi:10.1093/eurheartj/ehy504
   PubMed Web of Science ®Google Scholar
• Pasceri V, Patti G, Pelliccia F, et al. Complete revascularization during primary percutaneous coronary intervention reduces death and myocardial infarction in patients with multivessel disease: Meta-Analysis and Meta-Regression of Randomized Trials. JACC Cardiovasc Interv. 2018;11(9):833–843. doi:10.1016/j.jcin.2018.02.028
   Google Scholar
• Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2004;6(3–4):128–133. doi:10.1080/14628840310030441
   PubMedGoogle Scholar
• Hamza M, Mahmoud N, Elgendy IY. A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease. J Interv Cardiol. 2016;29(3):241–247. doi:10.1111/joic.12293
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038.
   PubMedGoogle Scholar
• Mohammed NMA, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart Views. 2013;14(3):106–116. doi:10.4103/1995-705X.125926
   PubMedGoogle Scholar
• Page MH, Julian; Sterne, Jonathan. Assessing risk of bias due to missing results in a synthesis. In: Cochrane, editor. Cochrane Handbook for Systematic Reviews of Interventions version 61 (updated September 2020): Cochrane;2020.
   Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986;7:177–88.
   Google Scholar
• Atti V, Gwon Y, Narayanan MA, et al. Multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease: meta-Analysis of Randomized Trials. JACC Cardiovasc Interv. 2020;13(13):1571–1582. doi:10.1016/j.jcin.2020.04.055
   Google Scholar
• Secemsky EA, Butala N, Raja A, et al. Temporal changes and institutional variation in use of percutaneous coronary intervention for ST-elevation myocardial infarction with multivessel coronary artery disease in the United States: an NCDR Research to Practice Project. JAMA Cardiol. 2020. doi:10.1016/S0735-1097(20)31755-1.
   Google Scholar
• Bossard M, Mehta SR. Complete or incomplete revascularization for ST-segment elevation myocardial infarction: the PRAMI Trial to COMPLETE. Interv Cardiol Clin. 2020;9(4):433–440. doi:10.1016/j.iccl.2020.06.001
   PubMedGoogle Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics - 2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–e596.
   PubMed Web of Science ®Google Scholar
• Magnani JW, Mujahid MS, Aronow HD, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation. 2018;138(2):e48–e74. doi:10.1161/CIR.0000000000000579
   PubMed Web of Science ®Google Scholar
• Bainey KR, Engstrøm T, Smits PC, et al. Complete vs Culprit-Lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. JAMA Cardiol. 2020;5(8):1–9. doi:10.1001/jamacardio.2020.1251
   Web of Science ®Google Scholar
• Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151–1158. doi:10.1016/S0735-1097(02)01726-6
   PubMed Web of Science ®Google Scholar
• Hayıroğlu M, Keskin M, Uzun AO, et al. Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging. 2018;34(3):329–336. doi:10.1007/s10554-017-1241-9
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Shaw RE, Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117(14):1787–1801. doi:10.1161/CIRCULATIONAHA.107.726562
   PubMed Web of Science ®Google Scholar
• Tuttle MK, Pinto DS. Culprit-only or complete revascularization for ST-elevation myocardial infarction in patients with and without shock. Interv Cardiol Clin. 2019;8(2):225–234. doi:10.1016/j.iccl.2019.01.001
   PubMedGoogle Scholar
• Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376(13):1234–1244. doi:10.1056/NEJMoa1701067
   PubMed Web of Science ®Google Scholar
• Ghani A, Dambrink JH, van ‘T Hof AW, Ottervanger JP, Gosselink AT, Hoorntje JC. Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial. Neth Heart J. 2012;20(9):347–353. doi:10.1007/s12471-012-0281-y
   PubMed Web of Science ®Google Scholar
• Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart (British Cardiac Society). 2010;96(9):662–667. doi:10.1136/hrt.2009.177162
   PubMed Web of Science ®Google Scholar